Leveraging our 85+ years of API development and manufacturing expertise to offer customized solutions.
With over 350 products in our portfolio, we’re the leading international supplier of APIs.
Meet us at DCAT Week as we showcase our integrated API and CDMO services. From complex API development to end-to-end manufacturing solutions, our team is ready to partner with you to advance high-quality, scalable pharmaceutical programs.
Since our founding in 1935, TAPI has been at the forefront of advancing health through innovation and dedication. Today we continue to build on this strong legacy, driving progress in the pharmaceutical industry. Our commitment to health is unwavering, from developing high-quality generics to pioneering cutting edge solutions.
Accelerating Peptide Innovation Through Science, Agility, and Collaboration
TAPI and Antheia Announce Strategic Partnership to Advance Commercialization of Biosynthetic Pharmaceutical Ingredients
Transforming GLP-1 Manufacturing with PAT-Generated Data: A Smarter, Greener Approach
Sustainable by Design: How TAPI is Building a Greener Future in API Manufacturing
How Innovative Computational Tools and Automation Are Reshaping Solid Form Development
Driving Innovation in Green Chemistry: Redox Biocatalysis Allowing Full Stereocontrol
Driving Bioprocess Innovation: How TAPI Is Transforming Fermentation Efficiency with Smart Automation
Strengthening Process Safety: Inside TAPI’s New HAZOP Training Program
Join us at World ADC London as we showcase our specialized CDMO services. Meet our experts, explore end-to-end development and manufacturing capabilities, and discover how we help partners accelerate high-quality, scalable ADC programs.
Meet us at DCAT Week as we showcase our integrated API and CDMO services. From complex API development to end-to-end manufacturing solutions, our team is ready to partner with you to advance high-quality, scalable pharmaceutical programs.
Visit us at CPHI Japan to explore our expertise in API development and manufacturing, complemented by our CDMO services. Our team is ready to partner with you on high-quality, scalable solutions that advance your pharmaceutical programs from development to commercial supply.
Our ESG commitment shapes how we develop, manufacture, and deliver active pharmaceutical ingredients (APIs) and CDMO services, with a long-term view toward shared value and global well-being.
We are committed to minimizing our environmental footprint by integrating eco-conscious practices into our production and supply chain. From investing in energy-efficient technologies to reducing water usage and chemical waste, we actively pursue greener processes without compromising quality or compliance.
We maintain rigorous compliance standards, transparent reporting, and ethical business practices across our global operations. From quality control to cybersecurity, our governance framework ensures accountability and risk management at every level.
People are at the heart of everything we do, and we collaborate with our partners and communities to promote health, education, and opportunity. Ethical labor practices, ongoing workforce development, and a commitment to health equity are key pillars of our social impact strategy.
